Cargando…

Pembrolizumab for the treatment of uveal melanoma: A case series

Uveal melanoma is a rare disease. Up to 50% of the patients will develop metastases for which the treatment options are limited. No randomized controlled data for the treatment of uveal melanoma patients are available. In this study we describe the clinical course of nine uveal melanoma patients inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jansen, Yanina Jeanne Leona, Seremet, Teofila, Neyns, Bart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675863/ https://www.ncbi.nlm.nih.gov/pubmed/33240475 http://dx.doi.org/10.1177/2036361320971983

Ejemplares similares

A Case Report of Long-Term Survival following Hepatic Arterial Infusion of L-Folinic Acid Modulated 5-Fluorouracil Combined with Intravenous Irinotecan and Cetuximab Followed by Hepatectomy in a Patient with Initially Unresectable Colorectal Liver Metastases
por: Van Bael, Kobe, et al.
Publicado: (2015)

A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab
por: Awada, Gil, et al.
Publicado: (2021)

Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse
por: Jansen, Yanina J. L., et al.
Publicado: (2021)

Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab
por: de Filette, Jeroen, et al.
Publicado: (2016)

Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors
por: Schreuer, Max, et al.
Publicado: (2016)

Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial
por: Schwarze, Julia Katharina, et al.
Publicado: (2022)

Pembrolizumab as first-line treatment for metastatic uveal melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report
por: Lambert, Ine, et al.
Publicado: (2021)

Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases
por: Jansen, Yanina J L, et al.
Publicado: (2019)

Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab
por: Du Four, Stephanie, et al.
Publicado: (2018)

Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy
por: Seremet, Teofila, et al.
Publicado: (2019)

Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients
por: Seremet, Teofila, et al.
Publicado: (2016)

Mobile Phone Use and Risk of Uveal Melanoma: Results of the Risk Factors for Uveal Melanoma Case-Control Study
por: Stang, Andreas, et al.
Publicado: (2009)

Uveal melanoma presenting as cataract and staphyloma
por: Khetan, Vikas, et al.
Publicado: (2009)

Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma
por: Karydis, Ioannis, et al.
Publicado: (2016)

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
por: Ny, Lars, et al.
Publicado: (2021)

Uveal melanoma incidentally diagnosed with neuroimaging, a case series of 3 patients
por: Tsukikawa, Mai, et al.
Publicado: (2021)

Clinicopathologic correlations in eyes enucleated after uveal melanoma resection with positive surgical margins
por: Khalifa, Yousuf, et al.
Publicado: (2007)

Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study
por: Qin, Yong, et al.
Publicado: (2017)

Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines
por: Nencetti, Susanna, et al.
Publicado: (2020)

Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients
por: Salaün, Hélène, et al.
Publicado: (2022)

BAP1 methylation: a prognostic marker of uveal melanoma metastasis
por: Bakhoum, Mathieu F., et al.
Publicado: (2021)

Combined treatment of uveal melanoma liver metastases
por: Brasiuniene, B, et al.
Publicado: (2011)

Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome
por: Vermeulen, Sim, et al.
Publicado: (2021)

Case report: an atypical peripapillary uveal melanoma
por: Lim, Li-Anne, et al.
Publicado: (2014)

Surgical treatment of liver metastasis with uveal melanoma: A case report
por: Kim, Young-Hun, et al.
Publicado: (2021)

“Giant cell arteritis manifesting as retinal arterial occlusion and paracentral acute middle maculopathy in a patient on pembrolizumab for metastatic uveal melanoma”
por: Narala, Ramsudha, et al.
Publicado: (2020)

Multicentric recurrent uveal melanoma
por: Menon, Vikas, et al.
Publicado: (2020)

Uveal Melanoma Metastasis to the Thyroid
por: Thanadar, Rokshana R., et al.
Publicado: (2023)

Gamma knife radiosurgery for the treatment of uveal melanoma and uveal metastases
por: Reynolds, Margaret M., et al.
Publicado: (2017)

Intratumoral bacteria in uveal melanoma: A case report
por: Vega Escobar, Katherine, et al.
Publicado: (2023)

Uveal Melanoma
por: Papastefanou, Vasilios P., et al.
Publicado: (2011)

Uveal Melanoma
por: Pfeffer, Ulrich
Publicado: (2019)

Clinical features and treatment outcomes of progressive uveal melanoma
por: Rancelyte, Milda, et al.
Publicado: (2023)

Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
por: Larsen, Frederik Uttenthal, et al.
Publicado: (2019)

Development and Validation of a Predictive Model for Metastatic Melanoma Patients Treated with Pembrolizumab Based on Automated Analysis of Whole-Body [(18)F]FDG PET/CT Imaging and Clinical Features
por: Dirks, Ine, et al.
Publicado: (2023)

Congenital uveal malignant melanoma- A rare case report
por: Tara, Shruthi, et al.
Publicado: (2022)

Radiation treatment methods in uveal melanoma
por: Tsotridou, Eleni, et al.
Publicado: (2021)

MRI of Uveal Melanoma
por: Ferreira, Teresa A., et al.
Publicado: (2019)

The biology of uveal melanoma
por: Amaro, Adriana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nqo1e30ng65s02bmfelq18h0fb